Decreased sensitivity of cucumber powdery mildew (Sphaerotheca fuliginea) to ergosterol biosynthesis inhibitors.

1988 ◽  
Vol 54 (5) ◽  
pp. 629-632 ◽  
Author(s):  
Norio OHTSUKA ◽  
Kazuhiro SOU ◽  
Tetsuo AMANO ◽  
Masahiro OJIMA ◽  
Yasuhiko NAKAZAWA ◽  
...  
1988 ◽  
Vol 28 (3) ◽  
pp. 417 ◽  
Author(s):  
RG O'Brien ◽  
LL Vawdrey ◽  
RJ Glass

Decreased fungicidal control of powdery mildew (Sphaerotheca fuliginea (Schlecht: Fr.) Poll.) in commercial cucurbit crops led to an investigation to determine whether fungicide resistant strains were present. In field trials, fungicides such as bupirimate (100 mg a.i. L-I), dimethirimol (250 mg a.i. L-1), fenarimol (36 mg a.i. L-1), penconazole (40 mg a.i. L-l) and triadimefon (125 mg a.i. L-1) were less effective (P=0.01) in controlling the disease than oxythioquinox (100 mg a.i. L-1). This disagreed with earlier trial results and suggested that fungicide resistant strains may have developed. The sensitiyities of 6 isolates of S. fuliginea to 12 fungicides were determined using a leaf disc technique. Two isolates collected in fields where fungicides had been used intensively showed reduced sensitivity to fungicides from several chemical groups including the ergosterol biosynthesis inhibitors, hydroxypyrimidines, organophosphates and benzimidazoles. Several spraying strategies were compared. The S. fuliginea populations receiving spray schedules which included the protectant fungicide oxythioquinox alone, or in alternation with a systemic (triadimefon) developed a lower proportion (66-73%) of resistant strains than those treated with systemic fungicide alone (89%). These findings suggest that S. fuliginea can develop strains with low sensitivity to several fungicides against powdery mildew. To prolong their efficacy, systemic fungicides should not be used continuously but should be reserved for use during the latter part of crop growth when disease risk is highest. Alternating or tank mixing with an effective protectant fungicide is also recommended.


2019 ◽  
Vol 67 (41) ◽  
pp. 11354-11363 ◽  
Author(s):  
Xiangmin Song ◽  
Xinyue Zhu ◽  
Ting Li ◽  
Cai Liang ◽  
Meng Zhang ◽  
...  

2003 ◽  
Vol 47 (3) ◽  
pp. 956-964 ◽  
Author(s):  
Chiatogu Onyewu ◽  
Jill R. Blankenship ◽  
Maurizio Del Poeta ◽  
Joseph Heitman

ABSTRACT Azoles target the ergosterol biosynthetic enzyme lanosterol 14α-demethylase and are a widely applied class of antifungal agents because of their broad therapeutic window, wide spectrum of activity, and low toxicity. Unfortunately, azoles are generally fungistatic and resistance to fluconazole is emerging in several fungal pathogens. We recently established that the protein phosphatase calcineurin allows survival of Candida albicans during the membrane stress exerted by azoles. The calcineurin inhibitors cyclosporine A (CsA) and tacrolimus (FK506) are dramatically synergistic with azoles, resulting in potent fungicidal activity, and mutant strains lacking calcineurin are markedly hypersensitive to azoles. Here we establish that drugs targeting other enzymes in the ergosterol biosynthetic pathway (terbinafine and fenpropimorph) also exhibit dramatic synergistic antifungal activity against wild-type C. albicans when used in conjunction with CsA and FK506. Similarly, C. albicans mutant strains lacking calcineurin B are markedly hypersensitive to terbinafine and fenpropimorph. The FK506 binding protein FKBP12 is required for FK506 synergism with ergosterol biosynthesis inhibitors, and a calcineurin mutation that confers FK506 resistance abolishes drug synergism. Additionally, we provide evidence of drug synergy between the nonimmunosuppressive FK506 analog L-685,818 and fenpropimorph or terbinafine against wild-type C. albicans. These drug combinations also exert synergistic effects against two other Candida species, C. glabrata and C. krusei, which are known for intrinsic or rapidly acquired resistance to azoles. These studies demonstrate that the activity of non-azole antifungal agents that target ergosterol biosynthesis can be enhanced by inhibition of the calcineurin signaling pathway, extending their spectrum of action and providing an alternative approach by which to overcome antifungal drug resistance.


1998 ◽  
Vol 8 (24) ◽  
pp. 3627-3630 ◽  
Author(s):  
Pierre Beuchet ◽  
Laïla El kihel ◽  
Michel Dherbomez ◽  
Georges Charles ◽  
Yves Letourneux

Sign in / Sign up

Export Citation Format

Share Document